BioLine RX Ltd - ADR (BLRX) stock is lower by -77.58% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives BLRX stock a score of 29 out of a possible 100.
That rank is chiefly influenced by a long-term technical score of 1. BLRX's rank also includes a short-term technical score of 16.
BLRX has an Overall Score of 29. Find out what this means to you and get the rest of the rankings on BLRX!
BioLine RX Ltd - ADR (BLRX) stock is higher by 5.17% while the S&P 500 has risen 1.04% as of 2:34 PM on Friday, Nov 11. BLRX has risen $0.03 from the previous closing price of $0.60 on volume of 820,588 shares. Over the past year the S&P 500 is down -14.02% while BLRX is lower by -77.58%. BLRX lost -$0.47 per share in the over the last 12 months.
Click Here to get the full Stock Report for BioLine RX Ltd - ADR stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
